Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBCG Vaccine
Dr. Girish S. Kulkarni, MD, PhD
NPI1942504667
- Publications
- 257
- Clinical trials
- 3
- Industry payments
- $1,913
- State license
- 1
- Year NPI issued
- 2011
- Practice address
- 1233 York Ave, New York, NY 10065-6306
- Practice phone
- Call (646) 717-1311
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Kulkarni's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Girish S. Kulkarni is a urologist in New York, New York
Dr. Kulkarni practices in New York, New York.
Dr. Kulkarni's NPI, 1942504667, was assigned on January 10, 2011. Dr. Kulkarni holds New York license P74140.
NPI and contact details
- NPI
- 1942504667NPI Registry (opens in a new tab)
- NPI enumeration date
- January 10, 2011
- NPI status
- Active
- Practice phone
- (646) 717-1311
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Girish S. Kulkarni's practice address is in New York, New York
Dr. Kulkarni's practice address in the NPI Registry is 1233 York Ave, New York, NY 10065-6306. The practice phone is (646) 717-1311.
- NPI Registry address1233 York Ave, New York, NY 10065-6306Phone(646) 717-1311
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Girish S. Kulkarni's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kulkarni practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Kulkarni's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kulkarni practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Girish S. Kulkarni is one of 919 urologists in New York
Urology is Dr. Kulkarni's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kulkarni is licensed in New York.
Specialties and state licenses
- Urology, New YorkPrimary
Urologists near Dr. Kulkarni
Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Girish S. Kulkarni has 257 publications on record
Dmand AI links 257 papers to Dr. Kulkarni, published from 2008 to 2025. 2018 was the busiest year, with 28. The most frequent topics are Prostatic Neoplasms, Urinary Bladder Neoplasms and Cystectomy. Dr. Kulkarni has published most often in Can Urol Assoc J. Dr. Kulkarni's most frequent co-authors are Andrew J. Evans, MD, Peter C. Black, MD and Thenappan M. Chandrasekar, MD.
Papers257
Years published2008 to 2025
Dr. Kulkarni's papers by year, 2016 to 2025
Topics Dr. Kulkarni writes about most
- Prostatic Neoplasms
- Urinary Bladder Neoplasms
- Cystectomy
- Ontario
- Neoplasm Grading
- Prostatectomy
- Neoplasm Invasiveness
- Prostate-Specific Antigen
Dr. Kulkarni's most frequent co-authors
- Andrew J. Evans, MD24 shared papers
- Peter C. Black, MD20 shared papers
- Thenappan M. Chandrasekar, MD15 shared papers
Recent publications by Dr. Kulkarni
Carcinoma in SituDisease ProgressionNeoplasm Invasiveness
Drug IndustryEquipment and SuppliesFellowships and Scholarships
CystoscopyDisease ProgressionNeoplasm Grading
See who Dr. Kulkarni researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kulkarni works with, so you can find a warm path to the right urologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Girish S. Kulkarni has worked on 3 clinical trials
Dmand AI links Dr. Kulkarni to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Urinary Bladder Neoplasms, Urinary Bladder Diseases and Prostatic Neoplasms.
Clinical trials with Dr. Kulkarni by phase
- NonePhase 1: no trials
- NonePhase 2: no trials
- 1Phase 2/3: 1 trial
- NonePhase 3: no trials
- 1Phase 4: 1 trial
Conditions in Dr. Kulkarni's trials
- Urinary Bladder Neoplasms
- Urinary Bladder Diseases
- Prostatic Neoplasms
- Prostatic Diseases
Investigators on the most trials with Dr. Kulkarni
- Bernard H. Bochner, MD1 shared trial
- John W. Colberg, MD1 shared trial
- Siamak Daneshmand, MD1 shared trial
Recent clinical trials with Dr. Kulkarni
Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With Metastatic Castrate Resistant Prostate Cancer (opens in a new tab)
Active, not recruitingPhase 4
Prostatic NeoplasmsProstatic DiseasesDexamethasone plus Radium-223
Tranexamic Acid During Cystectomy Trial (TACT) (opens in a new tab)
CompletedPhase 2/3
Urinary Bladder NeoplasmsUrinary Bladder DiseasesTranexamic Acid
Urinary Bladder NeoplasmsUrinary Bladder Diseases
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Girish S. Kulkarni received $1,913 in industry payments from 2019 to 2025
CMS Open Payments shows 8 general payments to Dr. Kulkarni from 3 drug and device companies from 2019 to 2025. Travel and lodging make up the largest share, 79% of the total. Ferring Pharmaceuticals Inc. paid the most, $1,724.
General payments to Dr. Kulkarni by program year, 2019 to 2025
General payments to Dr. Kulkarni by kind, 2019 to 2025
$1.9Kin total
- Travel and lodging$1,51479%
- Food and beverage$39921%
Companies that paid Dr. Kulkarni the most, 2019 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Girish S. Kulkarni's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Girish S. Kulkarni
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Girish S. Kulkarni's NPI number?
Dr. Girish S. Kulkarni's NPI number is 1942504667. It was assigned on January 10, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Girish S. Kulkarni?
Dr. Girish S. Kulkarni is a urologist in New York, New York. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).
Where does Dr. Girish S. Kulkarni practice?
Dr. Kulkarni practices at 1233 York Ave, New York, NY 10065-6306.
What is Dr. Girish S. Kulkarni's office phone number?
The practice phone on file for Dr. Kulkarni is (646) 717-1311.
What is Dr. Girish S. Kulkarni's medical license number?
Dr. Kulkarni holds New York license P74140.
Has Dr. Girish S. Kulkarni received payments from drug or device companies?
CMS Open Payments shows $1,913 in general payments to Dr. Kulkarni from 3 companies from 2019 to 2025. The largest total came from Ferring Pharmaceuticals Inc.
How long has Dr. Girish S. Kulkarni been practicing?
Dr. Kulkarni's NPI was assigned in 2011.
Does Dr. Girish S. Kulkarni do research?
Dmand AI links 257 publications to Dr. Kulkarni, published from 2008 to 2025. Dr. Kulkarni has worked on 3 clinical trials.
Who does Dr. Girish S. Kulkarni publish with?
Dr. Kulkarni's most frequent co-authors are Andrew J. Evans, MD (24 shared papers), Peter C. Black, MD (20 shared papers) and Thenappan M. Chandrasekar, MD (15 shared papers).
Selling to urology practices?
See urologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card